With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genomic Discovery of Wilms Tumor||Samuel Lunenfeld Research Institute of Mount Sinai Hospital / Rayjean Hung, PhD||Epidemiology Grants||2014||Ontario|
|Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma||University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD||Young Investigator Grants||2014||Hawaii|
|Epigenetic regulation of self-renewal pathways in hematopoietic and leukemic stem cells||George Washington University / Alexandros Tzatsos, MD/PhD||Young Investigator Grants||2012||District of Columbia|
|An Engineered Nanoimmunotherapy for Treating Neuroblastoma||George Washington University / Rohan Fernandes, PhD||'A' Award Grants||2016||District of Columbia|
|Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer||Boston University / Kristin Long, PhD||Psychosocial Grants||2014||Massachusetts|
|Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication||Marquette University / Amy Newman, RN, MSN||Nurse Researcher Grants||2014||Wisconsin|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma||Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)||Innovation Grants||2015||Virginia|
|Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified||Broad Institute / Rameen Beroukhim, MD,PhD||Innovation Grants||2015||Massachusetts|